[{"address1": "1500 Broadway", "address2": "Suite 1401", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 208 6102", "website": "https://www.nuvationbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its lead product candidate is taletrectinib, an ROS1 inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer; Safusidenib, a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; NUV-868, a binding domain 2 selective, oral, small molecule bromodomain and extra-terminal inhibitor that inhibits bromodomain-containing protein 4. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 220, "companyOfficers": [{"maxAge": 1, "name": "Dr. David T. Hung M.D.", "age": 66, "title": "Founder, President, CEO & Chairman", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 1000605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Hattersley Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 694558, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Liu M.D., Ph.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 677151, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philippe  Sauvage", "age": 47, "title": "Chief Financial Officer & Principal Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Moses  Makunje CPA", "age": 45, "title": "VP of Finance and Principal Accounting & Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Stephen  Dang", "title": "VP of Legal & Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Markel", "age": 59, "title": "Chief People Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David C. Hanley Ph.D.", "age": 54, "title": "Chief Technical Operations Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 586040, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kerry A. Wentworth", "age": 51, "title": "Chief Regulatory Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Colleen  Sjogren", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.21, "open": 2.24, "dayLow": 2.115, "dayHigh": 2.315, "regularMarketPreviousClose": 2.21, "regularMarketOpen": 2.24, "regularMarketDayLow": 2.115, "regularMarketDayHigh": 2.315, "payoutRatio": 0.0, "beta": 1.472, "forwardPE": -3.3968256, "volume": 3348309, "regularMarketVolume": 3348309, "averageVolume": 2689428, "averageVolume10days": 4128480, "averageDailyVolume10Day": 4128480, "bid": 2.11, "ask": 2.14, "bidSize": 30, "askSize": 40, "marketCap": 724773120, "fiftyTwoWeekLow": 1.67, "fiftyTwoWeekHigh": 4.16, "priceToSalesTrailing12Months": 92.05806, "fiftyDayAverage": 2.3626, "twoHundredDayAverage": 2.714, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 230995744, "profitMargins": 0.0, "floatShares": 228679350, "sharesOutstanding": 337679008, "sharesShort": 24656256, "sharesShortPriorMonth": 25210922, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0728, "heldPercentInsiders": 0.26679, "heldPercentInstitutions": 0.58951, "shortRatio": 14.36, "shortPercentOfFloat": 0.1019, "impliedSharesOutstanding": 338679008, "bookValue": 1.373, "priceToBook": 1.5586308, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -567939008, "trailingEps": -2.11, "forwardEps": -0.63, "enterpriseToRevenue": 29.34, "enterpriseToEbitda": -1.384, "52WeekChange": -0.053097367, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 2.14, "targetHighPrice": 10.0, "targetLowPrice": 5.0, "targetMeanPrice": 8.2, "targetMedianPrice": 10.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 502692000, "totalCashPerShare": 1.484, "ebitda": -166874000, "totalDebt": 8915000, "quickRatio": 8.911, "currentRatio": 9.035, "totalRevenue": 7873000, "debtToEquity": 1.922, "revenuePerShare": 0.029, "returnOnAssets": -0.18023, "returnOnEquity": -1.06265, "grossProfits": 795000, "freeCashflow": -52186248, "operatingCashflow": -130413000, "grossMargins": 0.10098, "ebitdaMargins": 0.0, "operatingMargins": -9.44528, "financialCurrency": "USD", "symbol": "NUVB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NYQ", "messageBoardId": "finmb_639036735", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1598448600000, "postMarketChangePercent": 0.934578, "corporateActions": [], "postMarketTime": 1741996729, "regularMarketTime": 1741982402, "regularMarketChangePercent": -3.16742, "regularMarketPrice": 2.14, "marketState": "CLOSED", "shortName": "Nuvation Bio Inc.", "longName": "Nuvation Bio Inc.", "postMarketPrice": 2.16, "postMarketChange": 0.02, "regularMarketChange": -0.0699999, "regularMarketDayRange": "2.115 - 2.315", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 2689428, "fiftyTwoWeekLowChange": 0.47000015, "fiftyTwoWeekLowChangePercent": 0.28143722, "fiftyTwoWeekRange": "1.67 - 4.16", "fiftyTwoWeekHighChange": -2.0199997, "fiftyTwoWeekHighChangePercent": -0.48557687, "fiftyTwoWeekChangePercent": -5.3097367, "earningsTimestamp": 1741296600, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.11, "epsForward": -0.63, "epsCurrentYear": -0.57, "priceEpsCurrentYear": -3.7543862, "fiftyDayAverageChange": -0.22259998, "fiftyDayAverageChangePercent": -0.094218224, "twoHundredDayAverageChange": -0.5739999, "twoHundredDayAverageChangePercent": -0.2114959, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "displayName": "Nuvation Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]